OncoImmune competitorsClear all

Spectrum Pharmaceuticals's top competitors include Halozyme Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Founding Date
Founding Date
2002
Founding Date
1998
Type
Type
Public
Type
Public
Tags
Locations
Locations
Henderson, US HQ
Irvine, US
Locations
San Diego, US HQ
Employees
Employees
14638% decrease
Employees
1363% increase
Valuation ($)
Valuation ($)
121.8 m
Valuation ($)
6.2 b
Employee Rating
Employee Rating
2.9
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$267.6m (FY, 2020)
Net income
Net income
($160.9m) (FY, 2020)
Net income
$129.1m (FY, 2020)

Operating

Phase I Trials Products
Phase I Trials Products
3 (FY, 2016)
Phase I Trials Products
10 (FY, 2020)
Phase II Trials Products
Phase II Trials Products
1 (FY, 2016)
Phase II Trials Products
1 (FY, 2020)
Phase III Trials Products
Phase III Trials Products
3 (FY, 2016)
Phase III Trials Products
8 (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 3m
Total funding raised
$ 45m
For sources of this data, please see the company profile

View company profiles

Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase

Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company